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Abstract 
 
Gonadotropins are indispensable in both sexes in the regulation of gonadal sex steroid 
production and gametogenesis. In addition to their well established classical actions, numerous 
recent publications have indicated the presence and function of luteinizing hormone/chorionic 
gonadotropin receptors (LH/hCG-R) in a variety of extragonadal tissues. However, the 
physiological significance of such effects has remained unclear. We have generated two 
genetically modified mouse models, one with excessive production of hCG and the other with 
targeted disruption of LH/hCG-R gene, and used them to address the functions of LH and hCG. 
Numerous gonadal and extragonadal phenotypes were found in the models with the two 
extremes of LH/hCG action. However, when the extragonadal effects were scrutinized in greater 
detail, they all appeared to arise through modification of gonadal function, either through 
enhanced or inhibited response to LH/hCG stimulation. Hence, further evidence is needed before 
the extragonadal LH/hCG-R expression can be considered functionally significant.  
 
Keywords: luteinizing hormone (LH), human chorionic gonadotropin (hCG), LH/hCG receptor 
(R), testis, ovary, transgenic mouse, knockout mouse, gonadal function, extragonadal LH/hCG 
action 
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1. Introduction 
The role of pituitary luteinizing hormone (LH) in the regulation of normal reproductive 
functions of males and females is well established. According to a generally accepted dogma, 
LH is secreted from the anterior pituitary gland under the stimulatory control of hypothalamic 
gonadotropin-releasing hormone (GnRH), and it acts by binding to its specific receptors 
(LH/hCG-R), which belong to the family of seven-times membrane spanning G-protein coupled 
receptors (McFarland et al., 1989; Ascoli et al., 2002). In gonads, the LH/hCG-Rs are situated in 
testicular Leydig cells and in ovarian theca, granulosa and luteal cells (Segaloff and Ascoli, 
1993; Dufau, 1998). LH has two roles in the regulation of gonadal function, i.e. to stimulate sex 
steroid synthesis and to regulate gametogenesis. Another hormone, human (h) chorionic 
gonadotropin (CG), is structurally related to LH, and both hormones bind to the common 
LH/hCG-R. The production of CG is confined to human, primate and equine placentas, whereas 
only pituitary LH is produced in rodents, including the mouse. hCG is essential for the 
maintenance of human pregnancy by stimulating progesterone production of corpus luteum 
gravidarum, and it also stimulates testosterone production of fetal Leydig cells (Huhtaniemi et 
al., 1977; Huhtaniemi and Pelliniemi, 1992; Huhtaniemi, 1994). In contrast to humans, the 
mouse genome does not contain a gene encoding chorionic gonadotroin. In contrast to humans, 
the sexual differentiation of male mice in utero can occur totally independent of LH/LHR action 
(El-Gehani et al., 1998; Pakarinen et al., 2002). 
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Numerous recent studies have provided evidence for the expression of LH/hCG-Rs in several 
extragonadal tissues, thus suggesting additional non-classical actions for LH and hCG (Rao, 
2001; Zhang et al., 2001b; Fields and Shemesh, 2004; Filicori et al., 2005). The novel actions 
suggested include improvement of blastocysts implantation (Han et al., 1999), regulation of 
oviduct and cervix function (Lei et al., 1993a; Lin et al., 2003), improvement of endometrial 
angiogenesis and growth (Filicori et al., 2005), and a role in brain development and sexual 
behaviour (Lei et al., 1993b; Apaja et al., 2004). However, despite the numerous findings on 
existence of extragonadal LH/hCG-Rs their physiological significance has remained unclear, and 
in vivo evidence for their functionality and necessity is lacking. We have generated two 
genetically modified mouse models to address LH/hCG actions in vivo from two opposite 
directions. One model is the hCG overexpressing transgenic (TG) mouse, producing either 
moderately or highly elevated levels of circulating bioactive LH/hCG (Rulli et al., 2002; Rulli et 
al., 2003). The other model is the LHR knockout mouse (LuRKO), totally devoid of functional 
LH/hCG-Rs and responsiveness to LH/hCG stimulation (Zhang et al., 2001a). We concentrate in 
this review on the findings in these two mouse models that are relevant for the unravelling of a 
physiological role for the extragonadally expressed LH/hCG-Rs. 
 
2. Classical gonadal actions of gonadotropins 
In females both gonadotropins are essential for fertility. LH/hCG-Rs are located in the ovary 
in theca cells, luteinizing granulosa cells and after ovulation in luteal cells, in the testis they are 
expressed in Leydig cells (Segaloff and Ascoli, 1993). Follicle-stimulating hormone (FSH) -R, in 
turn, is exclusively expressed in ovarian granulosa cells and testicular Sertoli cells (Simoni et al., 
1997). Follicular maturation and reproduction in females need the synergy and interaction of 
both follicular cell types; theca and granulosa cells (Gougeon, 1996). Under the influence of LH 
action, theca cells produce androgens, which thereafter are aromatized to estrogens in granulosa 
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cells. Both gonadotropins stimulate the expression of cytochrome P450-aromatase (P450-arom), 
which is needed for the aromatization of androgens to estrogens in granulosa cells (Hickey et al., 
1988). Furthermore, FSH stimulus increases the expression of LHR and other genes in the 
granulosa cells of preovulatory follicles (Richards, 1994). At the end of follicular development 
an LH peak is needed for triggering the cascade of events finally leading to ovulation. 
Thereafter, LH maintains the progesterone production of corpus luteum. In males, LH is 
indispensable for the Leydig cell production of androgens and indirectly for the maintenance of 
spermatogenesis through stimulation of Sertoli cell function. In light of the recently produced 
mouse knockouts and human mutations discovered in the gonadotropin and gonadotropin 
receptor genes, the need of FSH for male fertility is relative (Themmen and Huhtaniemi, 2000; 
Huhtaniemi and Themmen, 2005). 
 
3. Extragonadal effects of gonadotropins 
Most of the extragonadal, and also many of the gonadal effects of gonadotropins are indirect 
consequences of the stimulation of gonadal steroid biosynthesis. However, LH/hCG-R 
expression has been found in various non-gonadal tissues in humans and many animal species 
(Table 1). This has given rise to numerous suggestions for their novel physiological functions. 
Reports on extragonadal FSH-Rs are fewer, but there are reports on their presence in the bovine 
cervix, suggesting for them a role in the relaxation and opening of this structure (Mizrachi and 
Shemesh, 1999). Moreover, extrapituitary GnRH receptors have been found, and a role has been 
suggested for them as autocrine/paracrine regulators in the embryo-endometrial interaction 
during implantation (Raga et al., 1998). However, despite numerous studies showing the 
existence of extragonadal gonadotropin receptors with different molecular and biochemical 
methods, the physiological importance of these receptors in vivo has remained uncertain. The 
extragonadal LH/hCG-R expression differs in many respects from that of the gonadal receptors 
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(Stewart, 2001). For instance, reports of the molecular weights of the receptor protein and 
mRNA transcripts of the non-gonadal LHRs are at variance with the gonadal receptor. Although 
most of the data on extragonadal LH/hCG-R expression and function appear at face value 
convincing, several caveats remain.  Often only fragments of the LHR mRNA have been 
identified using RT-PCR, without evidence for functional full-length message. The size of 
immunoreactive LHR protein detected does not always agree with the authentic gonadal 
receptor, and the use heterologous antibodies reduce the specificity of immunodetection. Most of 
the functional data have been obtained from in vitro incubations and cell cultures, and 
compelling in vivo data are scarce. Moreover, human inactivating mutations of LHR have only 
gonadal phenotype, and all extragonadal effects can be explained by altered gonadal function 
(Themmen and Huhtaniemi, 2000).  
In addition to extragonadal gonadotropin receptors, there are also reports on production of 
gonadotropin subunits outside the pituitary gland. LHβ, FSHβ and common-α subunit expression 
at mRNA and protein level has been found in gonads, suggesting a paracrine pituitary 
independent component of gonadotropin action (Markkula et al., 1995; Zhang et al., 1995b; 
Zhang et al., 1995a; Markkula et al., 1996; Wong and Zohar, 2004). However, as with the 
receptors, the evidence for a physiologically significant role of the extrapituitary sources of 
gonadotropins is missing. 
 
4. hCG overexpressing transgenic mice 
Transgenic (TG) mice overexpressing hCGβ and common α-subunits under the human 
ubiquitin C promoter were produced by conventional pronuclear injection techniques (Rulli et 
al., 2002; Rulli et al., 2003). In these mice, the ubiquitin C promoter maintains low level TG 
expression in most tissue types, and its activity has been shown to start on embryonic day 10.5 
(Schorpp et al., 1996). In the hCGβ TG mice (hCGβ+), the hCGβ transgene is expressed also in 
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the pituitary cells expressing the endogenous common α-subunit. This enables dimerization of 
the TG and endogenous subunits to form biologically active hCG (human β/mouse α-subunit), 
inducing 3-4 fold elevation in hCG/LH bioactivity in males, but 30-fold increase in females 
compared to wild-type (WT) littermates (Rulli et al., 2002; Rulli et al., 2003). Phenotypic 
characterization of the hCGβ+ males revealed no obvious alterations, with the exception of 
slightly decreased testis weights most probably due to decreased FSH-levels seen in these males 
(Rulli et al., 2003). Simultaneously with our study, another group developed mice expressing the 
hCGβ-subunit under the metallothionein (MT-1) promoter (Matzuk et al., 2003). The male mice 
were infertile without elevated bioactive LH/hCG and without obvious testicular phenotype, and 
the authors speculate that high circulating hCGβ-subunit could bind to the LH/hCG-R and 
antagonize the effect of normal circulating LH, thus interfering with spermatogenesis in a 
quantitative manner (Matzuk et al., 2003). In the other TG mouse model, which expresses a 
fusion protein of the bovine LHβ subunit and  the hCGβ C-repminal peptide (bLHβ-CTP) under 
common α-subunit promoter, males did not show elevated LH/hCG-bioactivity and presented 
with no apparent phenotype (Risma et al., 1995).    
In contrast to hCGβ+ males, the hCGβ+ females presented with precocious puberty, 
disrupted estrous cycle, infertility and massive ovarian luteinization already as young adults 
(Rulli et al., 2002). As expected, we found elevated estradiol concentrations in prepubertal 
females, but surprisingly not in adult age, apparently due to the massive hCG-induced 
luteinization of all ovarian structures. Accordingly, serum progesterone concentration was 40-
100-fold and testosterone 3-8 fold elevated in adult hCGβ+ females (Rulli et al., 2002). Clear 
extragonadal phenotypes were also observed: the females developed obesity, pituitary 
macroprolactinomas, mammary gland adenocarcinomas, and their bone density was elevated 
(Rulli et al., 2002; Yarram et al., 2003) (see below).  However, all the extragonadal phenotypes 
of the hCGβ+ females were abolished by gonadectomy, indicating that ovarian hyperstimulation 
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and abnormal gonadal hormone production, rather than direct extragonadal hCG effects, was 
responsible for the extragonadal phenotypes observed in the hCGβ+ females (Figs. 1 and 2). 
Although there are some differences between ovarian steroidogenesis and ovarian tumor 
formation, many similarities exist between bLH-CTP overexpressing female mice and our mice, 
including the formation of pituitary and mammary gland tumors, obesity and infertility (Risma et 
al., 1995; Rulli et al., 2002; Kero et al., 2003; Mann et al., 2003; Mohammad et al., 2003). The 
ovarian tumor formation in bLHβ-CTP mice was found to be dependent on mouse strain (Keri et 
al., 2000), and we have not yet breed our mice to those strains susceptible to formation of 
ovarian tumors (Keri et al., 2000). Because the bioactive LH/hCG-levels and thus the ovarian 
steroidogenesis are higher in our mice than in the bLHβ-CTP mice, we expect to see ovarian 
tumor formation also in our mice when bred into an appropriate strain of mice. In the MT-1 
promoter driven hCGβ-females, infertility and in some cases ovarian cysts were seen, and the 
authors speculated that this is a result of inhibition of the normal LH-binding and/or disturbing 
some ovarian paracrine factors by free hCGβ-subunit rather than being a results of ovarian 
hyperstimulation, because no dimeric hCG was detected (Matzuk et al., 2003).  
In another model, we intercrossed the common-α and hCGβ overexpressing TG mice to 
achieve double-TG mice expressing both subunits (hCGαβ+). These mice presented with more 
than 1000-fold increase in serum LH/hCG bioactivity, because coexpression and dimerization of 
the two transgenic hCG subunits took place in most tissues, not only in the pituitary gland (Rulli 
et al., 2003). The hCGαβ+ males presented prepubertally with Leydig cell adenomas originating 
from fetal Leydig cells, but these neoplasms disappeared around the time of puberty, along with 
the regression of fetal Leydig cells according to their normal life span (Ahtiainen et al., 2005). In 
adult age, the hCGαβ+ males presented with elevated testosterone production accompanied by 
aggressive behaviour, hyperplasia of prostate and lower urinary tract obstruction with 
hydronephrosis and dilated urinary bladder without clear anatomical obstruction. The hCGαβ+ 
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males displayed qualitatively normal spermatogenesis, but were infertile apparently because of 
their aggressive behaviour upon breeding or the physiological (i.e. functional) obstruction of 
their lower urinary tract hindering normal ejaculation (Rulli et al., 2003). The extragonadal 
phenotypes observed in the hCGαβ+ males can be explained by the elevated testosterone 
production. However, further studies are needed because LH/hCG-R expression has been 
demonstrated in male urogenital organs (Table 1). Similar phenotype of adult male mice was 
observed in the other TG mouse model expressing both hCG-subunit under metallothionein 
promoter, although the development of fetal Leydig cell adenomas was not reported (Matzuk et 
al., 2003). 
The hCGαβ+ females were a close phenocopy of the hCGβ+ females except for one 
particular difference. Instead of the highly luteinized ovaries seen in hCGβ+ females, the 
hCGαβ+ females presented with germ cell tumors already before age of two months, and the 
tumors grew rapidly causing death of the mice before age of 6 months, before mammary gland 
adenocarcinomas and large macroprolactinomas were developed (Rulli et al., unpublished 
results). Gonadectomy prevented all phenotypic changes also in the hCGαβ+ females. In contrast 
to our mice, female mice expressing both hCG-subunits under metallothionein promoter showed 
cystic and hemorrhagic ovaries with the presence of hyperplastic theca-cell layers resembling 
ovarian thecomas. No reports on the formation of germ cell tumors exist on these mice (Matzuk 
et al., 2003). 
In summary, the TG models described above show that even in the presence of a very high 
level of hCG there were no extragonadal phenotypes in mice caused by extragonadal LH/hCG-R 
receptor activation. This was proven by the observation that all extragonadal phenotypes 
disappeared when the gonadal contribution to the responses was eliminated by gonadectomy. 
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5. LH/hCG-R knockout (LuRKO) mice 
The LHR knockout (LuRKO) mouse was developed by homologous recombination replacing 
exon 11 of the mouse LHR gene with the neo gene (Zhang et al., 2001a). The 11th exon encodes 
the cytoplasmic and transmembrane parts of the LHR and its targeted disruption totally 
inactivates the function of the receptor. LHR inactivation causes multiple reproductive and non-
reproductive phenotypes in the mice. The mice are born healthy with normal male and female 
appearance. However, in both sexes the LHR inactivation leads to multiple alterations in the 
reproductive tract starting at puberty. The lack of gonadal negative feedback on the 
hypothalamic-pituitary level induces elevated LH and FSH levels, whereas due to the gonadal 
unresponsiveness to LH circulating sex steroid concentrations are dramatically decreased, 
resulting in infertility in both sexes. The intratesticular testosterone level is reduced by 98% and 
the intraovarian estradiol level by >90%. The final preovulatory maturation of follicles is 
blocked, and consequently the females do not ovulate. The minimal sex steroid levels cause 
besides the absence of gametogenesis severe underdevelopment of the accessory sex organs. In 
males, spermatogenesis is arrested at the round spermatid stage, and the number and size of 
Leydig cells are remarkably reduced (Zhang et al., 2001a). Similar observations have been 
reported by Lei et al. with their LHR-KO mouse model (Lei et al., 2001). In females, the 
Graafian follicles do not develop beyond the antral stage and the ovaries reveal increased 
follicular apoptosis (Pakarainen et al., 2005b). In conclusion, poorly developed secondary sex 
characteristics and infertility are observed in both sexes. Further detail about the phenotype of 
this model are in our previous reports (Zhang et al., 2001a; Zhang et al., 2003; Zhang et al., 
2004; Pakarainen et al., 2005c; Pakarainen et al., 2005b; Pakarainen et al., 2005a). 
LHβ KO phenotype has been recently reported (Ma et al., 2004). As expected, the phenotype 
closely resembles that of LHR KO mice, with infertility of both sexes, hypoplastic sex organ 
development and reduced androgen and estrogen levels. Spermatogenesis was arrested, similar to 
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LHR KO mice, at the round spermatid stage and follicular development was arrested at the antral 
follicular stage. However, the LHβ KO mice, at variance with LHR KO mice, were reported to 
have unaltered FSH levels.  As expected, exogenous hCG treatment showed a response in LHβ 
KO mice and could even lead to ovulation in females.     
 
6. Bone phenotypes of LuRKO and hCG TG mice 
There are data on LHR expression in the bone based on Western blotting, 
immunolocalization and RT-PCR of mouse osteoblasts (Yarram et al., 2003). However, these 
studies were unable to show specific binding of iodinated hCG or hCG-stimulation of cAMP or 
phospohorylated ERK1/2, which findings left the functional significance of the positive findings 
open. This prompted us to look for a bone phenotype in the LuRKO and hCGαβ+ mice as 
evidence for or against direct actions of LH/hCG on the bone. LuRKO males but not females had 
decreased bone mineral density (BMD), whereas the hCGαβ+ females had increased, but males 
unaltered BMD in comparison to WT controls (Fig. 2). When the hCGαβ+ or WT females were 
ovariectomized, there was in both cases a significant decrease in BMD to a similar reduced level 
(Fig. 2). Taken together these data indicated that all effects found on bone density in the WT and 
the two genetically modified mouse models could be explained by modifications of gonadal 
activity. Most conspicuously, the increase in BMD seen in hCGαβ+ females was totally 
abolished and reversed to the same low level as in ovariectomized WT females, despite the 
persistent elevation of hCG in TG females (Yarram et al., 2003). It is apparent that ovarian 
estrogen production was the main factor determining BMD in these models. The findings, in 
fact, were quite similar with many of the other data on extragonadal LH/hCG action; they 
demonstrate low level of mRNA or protein expression, but the functional data often remain 
inconclusive. 
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7. Orthotopic ovarian transplantation in LuRKO mice 
Due to the difficulties in discriminating between direct and indirect actions of LH/hCG and to 
clarify the real functional significance of the extragonadal LH/hCG-R in vivo, we carried out 
orthotopic ovarian transplantations in LuRKO mice (Pakarainen et al., 2005a). We replaced 
bilaterally the ovaries of LuRKO mice with pieces of WT ovaries by a method described 
previously (Lavebratt et al., 1998) . Thus, the transplanted mice were devoid of functional LHRs 
in all other tissues except for the transplanted WT ovarian tissue. A dramatic suppression of 
endogenous LH level of LuRKO mice indicated onset of sex steroid production by the 
transplanted tissue, which in turn induced accessory sex organ growth, and macroscopically the 
transplanted LuRKO (LuRKO-TR) mice were indistinguishable from WT mice at the age of 3 
months. Furthermore, the transplanted ovaries functioned in a normal cyclic manner and follicles 
of all developmental stage could be seen upon histological study (Fig. 3). Test breedings of the 
LuRKO-TR mice indicated that they had gained normal fertility and were able to deliver healthy 
offspring (Table 2). Fertility rate of the LuRKO-TR females was slightly lower than that of 
similarly transplanted WT control females. However, the difference was not statistically 
significant, and it was likely due to the fact that transplantations were technically more 
demanding in LuRKO mice because of their smaller ovaries and uteri at the time of 
transplantation. The complete recovery of fertility in LuRKO females after ovarian 
transplantation, including normal estrous cycle, mating behaviour, pregnancy rate, delivery and 
normal nursing and feeding of offspring, clearly indicated that extragonadal LH/hCG-R are 
redundant for mouse reproductive functions. 
Rao et al. studied the implantation capability of their LHR KO model by stimulating the mice 
with estradiol, PMSG and hCG, and made in vitro fertilizations (IVF) (Rao and Lei, 2002). They 
failed to induce implantation and pregnancy, and considered this as evidence for a functional role 
of the uterine LHRs. However, there are multiple technical limitations in this type of 
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experiments. Especially if the results are negative, in the absence of positive control, it remains a 
possibility that the exogenous hormone treatment has not been able to simulate completely that 
caused by endogenous hormones. The same auhors were also unable to achieve pregnancies 
following orthotopic transplantations of WT ovarian tissue in their LHR KO mice (Chudgar et 
al., 2005), which negative finding also remains inconclusive. 
 
7. Concluding remarks 
In contrast to the recent suggestions on direct actions of LH/hCG-R in multiple non-gonadal 
tissues, our studies with the two mouse models were unable to provide data in support of such 
actions. In contrast, in light of our findings, the extragonadal LH/hCG-R appeared redundant. 
The hCG overexpressing TG mouse models produce pharmacological levels of hCG, which was 
shown to induce tumorigenic effects in female mice. However, the tumor formation was directly 
related to the gonadal sex steroid production, and the pituitary and mammary gland 
tumorigenesis could be prevented by ovariectomy. Thus, even at pharmacological levels of hCG 
we were not able do recognize apparent extragonadal phenotypes induced in the absence of 
gonadal response. Furthermore, all the phenotypes so far detected in LuRKO mice could be 
explained on the basis of reduced sex st roid production. The ovarian transplantations confirmed 
this and demonstrated that the infertility of LuRKO females was caused solely by the lack of LH 
signalling in the ovaries, and the extragonadal LH/hCG-Rs did not play a role in fertility of the 
female mice. Hence, on the basis of these observations it is too early to call for a paradigm shift 
in the classification of gonadotropin action from being specifically targeted to gonads to a more 
general hormone also regulating functions of non-gonadal organs.     
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Figure legends: 
 
Fig. 1.  Effect of gonadectomy on some extragonadal phenotypes of the hCGβ+ females. The 
upper part  of the figure shown pituitary gland weights (panel A) and serum prolactin 
concentrations (panel B) of WT control (filled circles) and hCGβ+ (open circles) females. 
Diamond-shaped symbol shows the values of gonadectomized hCGβ+ females, which are at 
level of WT controls. The lower part of the figure shows whole-mount images of mammary 
gland lobuloalveolar development in 6-month-old WT (panel C), hCGβ+ (panel D), 
ovariectomized (ovx) WT (panel E) and ovx hCGβ+ (panel F) females. Lobuloalveolar 
development is not seen in ovx WT and hCGβ+ females. Scale bars = 400 µm, modified from 
Rulli et al. (2002). 
 
 
Fig 2. Bone mineral densities (BMD) of LuRKO and hCGαβ+ mice assessed by DXA. Panel A 
show BMDs of untreated 9-10 week-old LuRKO females, 5-months-old LuRKO males and 6-
month-old hCGαβ females and males. LuRKO males and hCGαβ+ females present significant 
difference between age-matched WT controls in BMD of both femur and tibia (*** , P<0.0001, 
**, P<0.003). Figure B shows the effect of ovariectomy (ovx) at the age of 3 weeks on hCGαβ+ 
females, sacrificed at the age of 8 weeks. Ovariectomy reduces BMD of the hCGαβ+ females to 
the same level as in ovariectomized WT controls. Letter a indicates significant difference (P < 
0.001) between the hCGαβ+ females and all other group. Asterisks denote significant difference 
between the WT females and ovariectomized WT and hCGαβ+ females (**, P<0.01, ***, 
P<0.001). Letters ns in the hCGαβ+ ovx bar denotes that significant differences between the WT 
ovx and  hCGαβ+ ovx groups were not found. Modified from Yarram et al. (2003). 
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Figure 3. Representative light microscopic images of the ovaries of LuRKO (A), WT ovary-
transplanted LuRKO (B), WT ovary-transplanted WT (C) and control WT (D) mice. CL, corpus 
luteum. Scale bars 500 µm. Modified from Pakarainen et al. (2005a).  
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Table 1. LH/hCG receptors found in humans and rodents in extragonadal tissues.
Tissue Species References
Adrenal gland human Pabon et al. 1996b
rat Apaja et al. 2005
Blood vessel* human Reshef et al. 1990
Lei et al. 1992
Brain rat Lei et al. 1993b
Apaja et al. 2004
Cervix human Lin et al. 2003
Fetal tissues** human Abdallah et al. 2004
Kidney rat Apaja et al. 2005
Lymphocyte human Lin et al. 1995
Mammary gland rat Tao et al. 1997 
Oviduct human Lei et al. 1993a
Han et al. 1996
mouse Zhang et al. 2001b
Placenta human Reshef et al. 1990
Prostate rat Tao et al. 1995
Reiter et al. 1995
Seminal vesicle rat Tao et al. 1998
Skin human Pabon et al. 1996a
Venencie et al. 1999
Sperm human Eblen et al. 2001
Spinal cord rat Rao et al. 2003
Umbilical cord human Rao et al. 1993
Uterus human Han et al. 1997
Reshef et al. 1990
mouse Zhang et al. 2001b
*endometrial and myometrial blood vessels of thwuterus; **fetal kidneys, liver, 
pancreas, lung, small and large intestines, and adrenals.
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1st pregnancy 2nd pregnancy 3rd pregnancy
Vaginal plug 1st Litter 2nd Litter 3rd Litter
Size N      % /all     % /normal Size N       % /all Size N       % /all
LuRKO-TR 19/20  (95 %) 4.2 ± 2.4 9      45 %A 56 %A 4.0 ± 2.1A 9       100 % 2.9 ± 1.1A 9        100 %
WT-TR 21/22 (95 %) 4.4 ± 2.3 16      73 %A 80 %A 5.2 ± 3.0AB  12 75 % 4.8 ± 2.7AB    8       67 %
WT 10/10 (100 %) 6.0 ± 2.4 10    100 %B 100 %B 7.9 ± 2.2B 9       100 % 7.2 ± 2.8B 9        100 %
HZ - 5.5 ± 2.6 52     - 5.6 ± 2.6AB  37   - 6.7 ± 2.4B 22 -
Table 2. Mating incidence on the 1st breeding, and litter sizes following the 1st, 2nd and 3rd pregnancy of LuRKO-TR, WT-TR, WT and 
heterozygous (HZ) mice (Pakarainen et al., 2005a).
N = number of litters born; % /all = % of pregnancy of females mated; % /normal = % of pregnancy rate of females with no obvious explanation 
for infertility. The groups provided with different superscripts are significantly different (p < 0.05).-, not studied. All figures are mean ± SD.
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